rs3828735

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000426.4(LAMA2):​c.5727-24T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 1,594,536 control chromosomes in the GnomAD database, including 176,592 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19480 hom., cov: 32)
Exomes 𝑓: 0.46 ( 157112 hom. )

Consequence

LAMA2
NM_000426.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.28

Publications

4 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-129403797-T-A is Benign according to our data. Variant chr6-129403797-T-A is described in ClinVar as Benign. ClinVar VariationId is 256076.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA2NM_000426.4 linkc.5727-24T>A intron_variant Intron 39 of 64 ENST00000421865.3 NP_000417.3
LAMA2NM_001079823.2 linkc.5727-24T>A intron_variant Intron 39 of 63 NP_001073291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA2ENST00000421865.3 linkc.5727-24T>A intron_variant Intron 39 of 64 5 NM_000426.4 ENSP00000400365.2 P24043
LAMA2ENST00000618192.5 linkc.5991-24T>A intron_variant Intron 40 of 65 5 ENSP00000480802.2 A0A087WX80
LAMA2ENST00000617695.5 linkc.5727-24T>A intron_variant Intron 39 of 63 5 ENSP00000481744.2 A0A087WYF1

Frequencies

GnomAD3 genomes
AF:
0.501
AC:
75842
AN:
151470
Hom.:
19436
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.615
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.458
Gnomad ASJ
AF:
0.512
Gnomad EAS
AF:
0.546
Gnomad SAS
AF:
0.527
Gnomad FIN
AF:
0.438
Gnomad MID
AF:
0.474
Gnomad NFE
AF:
0.445
Gnomad OTH
AF:
0.493
GnomAD2 exomes
AF:
0.485
AC:
121078
AN:
249442
AF XY:
0.485
show subpopulations
Gnomad AFR exome
AF:
0.619
Gnomad AMR exome
AF:
0.467
Gnomad ASJ exome
AF:
0.527
Gnomad EAS exome
AF:
0.567
Gnomad FIN exome
AF:
0.445
Gnomad NFE exome
AF:
0.449
Gnomad OTH exome
AF:
0.472
GnomAD4 exome
AF:
0.462
AC:
667086
AN:
1442946
Hom.:
157112
Cov.:
32
AF XY:
0.464
AC XY:
333496
AN XY:
718816
show subpopulations
African (AFR)
AF:
0.630
AC:
20824
AN:
33044
American (AMR)
AF:
0.473
AC:
21119
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.530
AC:
13799
AN:
26016
East Asian (EAS)
AF:
0.531
AC:
21036
AN:
39590
South Asian (SAS)
AF:
0.539
AC:
46311
AN:
85884
European-Finnish (FIN)
AF:
0.457
AC:
23972
AN:
52492
Middle Eastern (MID)
AF:
0.511
AC:
2935
AN:
5742
European-Non Finnish (NFE)
AF:
0.446
AC:
488797
AN:
1095670
Other (OTH)
AF:
0.473
AC:
28293
AN:
59818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.434
Heterozygous variant carriers
0
16156
32312
48468
64624
80780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14792
29584
44376
59168
73960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.501
AC:
75955
AN:
151590
Hom.:
19480
Cov.:
32
AF XY:
0.501
AC XY:
37119
AN XY:
74036
show subpopulations
African (AFR)
AF:
0.616
AC:
25437
AN:
41296
American (AMR)
AF:
0.458
AC:
6984
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
1772
AN:
3464
East Asian (EAS)
AF:
0.547
AC:
2806
AN:
5132
South Asian (SAS)
AF:
0.529
AC:
2546
AN:
4812
European-Finnish (FIN)
AF:
0.438
AC:
4598
AN:
10502
Middle Eastern (MID)
AF:
0.479
AC:
140
AN:
292
European-Non Finnish (NFE)
AF:
0.445
AC:
30211
AN:
67826
Other (OTH)
AF:
0.491
AC:
1036
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1908
3816
5724
7632
9540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
1773
Bravo
AF:
0.509
Asia WGS
AF:
0.510
AC:
1775
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Merosin deficient congenital muscular dystrophy Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Muscular dystrophy, limb-girdle, autosomal recessive 23 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
3.5
DANN
Benign
0.74
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3828735; hg19: chr6-129724942; COSMIC: COSV70353211; API